Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1584-1591

  Hori, Yozo ^a   Hu, De En ^a   Yasui, Kiyoshi ^c   Smither, Rachel L ^a   Gresham, G Austin ^b   Fan, Tai Ping D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

Angiogenesis; Angiostatic steroids; Anti inflammatory steroids; Inflammation; Interleukin 6; Tumour necrosis factor

Indexed keywords

6 ALPHA FLUORO 17,21 DIHYDROXY 16 ALPHA METHYLPREGNA 4,9(11) DIENE 3,20 DIONE 21 ACETATE; CYTOKINE; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 6; POLYETHER; STEROID; TUMOR NECROSIS FACTOR ALPHA; U 24067; UNCLASSIFIED DRUG; XENON 133;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HISTOLOGY; IMMUNOMODULATION; IMPLANT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SPLEEN; SPLEEN WEIGHT; SUBCUTANEOUS DRUG ADMINISTRATION; THYMUS;

EID: 0029946393     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15578.x     Document Type: Article

References (48)

1. AGGAWAL, B.B., KOHR, W.J., HASS, P.E., MOFFAT, B., SPENCER, S.A., HENZEL, W.J., BRINGMAN, T.S., NEDWIN, G.E., GOEDEL, D.V. & HARKINS, R.N. (1985). Human tumor necrosis factor: production, purification, and characterization. J. Biol. Chem., 260, 2345-2354.
2. ANDRADE, S.P., FAN, T.-P.D. & LEWIS, G.P. (1987). Quantitative in vivo studies on angiogenesis in a rat sponge model. Br. J. Exp. Pathol., 68, 755-766.
3. BARNES, P.J. & ADCOCK, I. (1993). Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci., 14, 436-441.
4. BLAUER, K.L., POTH, M., ROGERS, W.M. & BERNTON, E.W. (1991). Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinol., 129, 3174-3179.
5. BLEI, F., WILSON, E.L., MIGNATTI, P. & RIFKIN, D.B. (1993). Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J. Cell. Physiol., 155, 568-578.
6. COLVILLE-NASH, P.R., ALAM, C., APPLETON, I., BROWN, J.R., SEED, M.P. & WILLOUGHBY, D.A. (1995). The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J. Pharmacol. Exp. Ther., 274, 1463-1472.
7. COLVILLE-NASH, P.R., EL-GHAZALY, M. & WILLOUGHBY, D.A. (1993). The use of angiostatic steroids to inhibit cartilage destruction in an in vivo model of granuloma-mediated cartilage degradation. Agents Actions, 38, 126-134.
8. COLVILLE-NASH, P.R. & SCOTT, D.L. (1992). Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann. Rheum. Dis., 51, 919-925.
9. CRONSTEIN, B.N., KIMMEL, S.C. LEVIN, R.I., MARTINIUK, F. & WEISSMANN, G. (1992). A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intracellular adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A., 89, 9991-9995.
10. CRUM, R., SZABO, S. & FOLKMAN, J. (1985). A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science, 230, 1375-1378.
11. FAJARDO, L.F., KWAN, H.H., KOWALSKI, J., PRIONAS, S.D. & ALLISON, A.C. (1992). Dual role of tumor necrosis factor-α in angiogenesis. Am. J. Pathol., 140, 539-544.
12. FAN, T.-P.D., JAGGAR, R. & BICKNELL, R. (1995). Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci., 16, 57-66.
13. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1, 27-31.
14. FOLKMAN, J. & BREM, H. (1992). Angiogenesis and inflammation. In Inflammation: Basic Principles and Clinical Correlates, 2nd edition. ed. Gallin, J.I., Goldstein, I.M. & Snyderman, R. pp. 821-839. New York: Raven Press.
15. FOLKMAN, J. & INGBER, D.E. (1987). Angiostatic steroids. Method of discovery and mechanism of action. Ann. Surg., 206, 374-383.
16. FOLKMAN, J., LANGER, R., LINHARDT, R.T., HAUDENSCHILD, C. & TAYLOR, S. (1983). Angiogenesis inhibition and tumour regression caused by heparin or a heparin fragment in the presence of cortisone. Science, 221, 719-725.
17. FOLKMAN, J. & SHING, Y. (1992). Angiogenesis. J. Biol. Chem., 267, 10931-10934.
18. FOLKMAN, J., WEISZ, P.B., JOULLIE, M.M., LI, W.W. & EWING, W.R. (1989). Control of angiogenesis with synthetic heparin substitutes. Science, 243, 1490-1493.
19. FRÁTER-SCHRÖDER, M., RISAU, W., HALLMAN, R., GAUTSCHI, P. & BOHLEN, P. (1987). Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. U.S.A., 84, 5277-5281.
20. GAY, C.G. & WINKLES, J.A. (1991). Interleukin I regulates heparinbinding growth factor 2 gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 88, 296-300.
21. GROSS, J., AZIZKAHN, R.G., BISWAS, C., BRUNS, R.R., HSIEH, D.S.T. & FOLKMAN, J. (1981). Inhibition of tumor growth, vascularization and collagenolysis in the rabbit cornea by medroxy-progesterone. Proc. Natl. Acad. Sci. U.S.A., 78, 1176-1180.
22. HAYNES, R.C., JR. (1990). Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In Goodman and Gilman's Pharmacological Basis of Therapeutics, 8th edition. ed. Gilman, A., Roll, T.W., Nies, A.S. & Taylor, P. pp. 1431-1462. New York: Pergamon Press.
23. HU, D.E. & FAN, T.-P.D. (1992). The combined use of dehydroepian-drosterone and dexamethasone inhibits angiogenesis in the rat without causing immunosuppression. Br. J. Pharmacol., 107, 260P.
24. 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers. Lab. Invest., 72, 601-610.
25. HU, D.E., HORI, Y., PRESTA, M., GRESHAM, G.A. & FAN, T.-P.D. (1994). Inhibition of angiogenesis by IL-1 receptor antagonist and selected cytokine antibodies in rats. Inflammation, 18, 45-58.
26. INGBER, D.E. & FOLKMAN, J. (1988). Inhibition of angiogenesis through modulation of collagen metabolism. Lab. Invest., 59, 44-51.
27. INGBER, D.E., MADRI, J.A. & FOLKMAN, J. (1986). A possible mechanism for inhibition of angiogenesis by angiogenic steroids: induction of capillary basement membrane dissolution. Endocrinol., 119, 1768-1785.
28. KOCH, A.E., HALLORAN, M.M., HASKELL, C.J., SHAH, M.R. & POLVERINI, P.J. (1995). Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature, 376, 517-519.
29. LAITINEN, L. (1987). Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem., 19, 225-234.
30. LEE, J.K., CHOI, B., SOBEL, R.A., CHIOCCA, E.A. & MARTUZA, R.L. (1990). Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. J. Neurosurg., 73, 429-435.
31. LEE, S.W., TSOU, A.-P., CHAN, H., THOMAS, J., PETRIE, K., EUGUI, E.M. & ALLISON, A.C. (1988). Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. U.S.A., 85, 1204-1208.
32. LEIBOVICH, S.J., POLVLERINI, P.J., SHEPARD, H.M., WISEMAN, D.M., SHIVELY, V. & NUSEIR, N. (1987). Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature, 329, 630-632.
33. MARAGOUDAKIS, M.E., SARMONIKA, M & PANOUT-SACOPOULOU, M. (1989). Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system. J. Pharmacol. Exp. Ther., 251, 679-682.
34. MATSUDA, T., HIRANO, T. & KISHIMOTO, T. (1988). Establishment of an interleukin 6 (IL-6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur. J. Immunol., 18, 951-956.
35. MAY, L.T., TORCIA, G., COZZOLINO, F., RAY, A., TATTER, S.B., SANTHANAM, U., SEHGAL, P.B. & STERN, D. (1989). Interleukin-6 gene expression in human endothelial cells - RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem. Biophys. Res. Commun., 159, 991-998.
36. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
37. MOTRO, B., ITIN, A., SACHS, L. & KESHET, E. (1990). Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. U.S.A., 87, 3092-3096.
38. NGUYEN, M., SHING, Y. & FOLKMAN, J. (1994). Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res., 47, 31-40.
39. PEACOCK, D.J., BANQUERIGO, M.L. & BRAHN, E. (1992). Angiogenesis inhibition suppresses collagen arthritis. J. Exp. Med., 175, 1135-1138.
40. PENHALIGON, M. & CAMPLEJOHN, R.S. (1985). Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice. J. Natl. Cancer Inst., 74, 869-873.
41. SAKAMOTO, N., TANAKA, N.G., TOHOGO, A., OSADA, Y. & OGAWA, H. (1987). Inhibitory effects of heparin plus cortisone acetate on endothelial cell growth both in cultures and in tumor masses. J. Natl. Cancer Inst., 78, 581-585.
42. SMITHER, R.L. & FAN, T.-P.D. (1991). Role of arachidonic acid metabolites in a rat sponge model of angiogenesis. Int. J. Radiat. Biol., 60, 48P.
43. STOKES, C.L., WEISZ, P.B., WILLIAMS, S.K. & LAUFFENBURFER, D.A. (1990). Inhibition of microvascular endothelial cell migration by beta-cyclodextrin tetradecasulfate and hydrocortisone. Microvasc. Res., 40, 279-284.
44. TAMARGO, R.J., LEONG, K.W. & BREM, H. (1990). Inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J. Neurooncol., 9, 131-138.
45. TEALE, D.M., UNDERWOOD, J.C.E., POTTER, C.W. & REES, R.C. (1987). Therapy of spontaneously metastatic HSV-2 induced hamster tumours with cortisone acetate administered with or without heparin. Eur. J. Cancer Clin. Oncol., 23, 93-100.
46. WAAGE, A., SLUPPHAUG, G. & SHALABY, R. (1990). Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur. J. Immunol., 20, 2439-2443.
47. WILKS, J.W., SCOTT, P.S., VRBA, L.K. & COCUZZA, J.M. (1991). Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int. J. Radiat. Biol., 60, 73-77.
48. 1 and by S180 cells, and on growth of murine transplantable tumours. Int. J. Cancer, 35, 549-552.